Clinical Trial Update: A Phase II Study of Atezolizumab in Combination With Cisplatin + Gemcitabine Before Surgery to Remove the Bladder Cancer [Phase 1, Phase 2]

View source ↗

Summary

Update on a Phase II study evaluating Atezolizumab with cisplatin and gemcitabine as neoadjuvant therapy for bladder cancer; the trial is currently active but n…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer
• Urothelial Carcinoma

Drugs mentioned

• Atezolizumab (atezolizumab)
• CISPLATIN (cisplatin)
• Gemcitabine (Gemcitabine)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Bladder Cancer, Metastatic Bladder Cancer | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING